FLUOROURACIL, BEVACIZUMAB, FOLINIC ACID, OXALIPLATIN, ivonescimab
SMT112-3005
Phase 3 small_molecule active
Quick answer
FLUOROURACIL, BEVACIZUMAB, FOLINIC ACID, OXALIPLATIN, ivonescimab for Metastatic colorectal cancer is a Phase 3 program (small_molecule) at Summit Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Summit Therapeutics
- Indication
- Metastatic colorectal cancer
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active